Sutro Biopharma's total assets for Q4 2024 were $387.21M, a decrease of -14.30% from the previous quarter. STRO total liabilities were $342.61M for the fiscal quarter, a 0.59% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.